
You can purchase shares of THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (OTCQB:TTIPF) through any online brokerage.
There are no as such competitors for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp..
There is no analysis for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. to provide a consensus price target.
The stock price for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (OTCQB: TTIPF) is $0.3737 last updated October 23, 2026 at 11:01 AM EDT.
There are no upcoming dividends for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp..
THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. does not have any upcoming earnings scheduled.
There is no upcoming split for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp..
THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.
Thiogenesis Therapeutics Corp is a clinical-stage biotechnology company developing TTI-0102, a novel controlled-release cysteamine prodrug designed to improve tolerability and dosing relative to existing therapies. The Company is focused on TTI-0102...